Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Arbele’s ARB202 Enters Phase I Trial for Advanced Gastrointestinal Cancer

February 15, 2025
DealsHospital

ByteDance Acquires Amcare Healthcare for USD1.5b via Xiaohe Health Unit

February 15, 2025
CompanyDeals

Taihu Bay Healthcare Conference Launches Wuxi IP Protection Center

February 15, 2025
CompanyDeals

United Imaging Healthcare’s STAR Listing Raises USD1.85 Billion

February 15, 2025
CompanyMedical Device

Boston Scientific’s Rezūm System Installed in China’s Urinary Innovation Center

February 15, 2025
CompanyDeals

Trautec Medical Raises RMB200m in Series A Financing for Recombinant Collagen R&D

February 15, 2025
Drug

Zhaoke Ophthalmology Enrolls First Patient in ZKY001 Phase II TPRK Study

February 15, 2025
CompanyDeals

Insilico Medicine Closes USD95m Series D Financing to Advance AI Drug Discovery

February 15, 2025
CompanyDrug

LianBio Completes Enrollment for Mavacamten Phase III Trial in oHCM

February 15, 2025
CompanyDeals

Huadong Medicine to Acquire 60% Stake in Wuhu Huaren for RMB 396 Million

February 15, 2025
CompanyDrug

Recbio Completes Enrollment for HPV Vaccine REC603 Immuno-Bridging Study

February 15, 2025
CompanyDeals

Everest Medicines’ Xerava NDA Accepted by Taiwan’s TFDA

February 15, 2025
1 2 … 12 13 14 15 16 … 21 22
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up